300060267024

The barcode 300060267024 is associated with Rizatriptan, a medication produced by Merck Sharp & Dohme, specifically in its Maxalt formulation. Maxalt is an effective treatment for acute migraine attacks in adults and is often used when patients have a clear diagnosis of migraine without aura.

Key Details about Rizatriptan (Maxalt):

• Formulation: Available in tablet forms, typically in doses of 5mg and 10mg.
• Indication: Designed to alleviate migraine headaches once they occur. It is not intended for preventive treatment.

Pricing:

Prices for Rizatriptan can vary based on factors such as location, pharmacy choice, and whether the patient has insurance. Estimates for a pack of 30 tablets (either 5mg or 10mg) suggest a range from $15 to $40 USD.

Health-Related Warnings and Concerns:

• Allergic Reactions: Patients should be aware of the potential for allergic reactions, presenting as skin rash, itching, or respiratory difficulties.
• Cardiovascular Risks: There is a possibility of increased blood pressure and heart rate, which warrants caution in patients with pre-existing heart conditions.
• Side Effects: Common side effects may include dizziness, drowsiness, or lightheadedness, stemming from its effects on blood vessels.
• Withdrawal Issues: Sudden discontinuation of Rizatriptan can lead to withdrawal headaches, which may mimic migraine symptoms.

As noted, it's essential for individuals considering or currently using this medication to follow the guidance of their healthcare provider for personalized treatment and advice. There are no specific health-related disclaimer notices associated with this product, as it requires a prescription and should be used under medical supervision.